Safety of meloxicam in patients with aspirin/non-steroidal anti-inflammatory drug-induced urticaria and angioedema.
Göksel
Ozlem
O
Department of Immunology and Allergy, Ankara University School of Medicine, Ankara, Turkey.
Aydin
Omür
O
Misirligil
Zeynep
Z
Demirel
Yavuz S
YS
Bavbek
Sevim
S
D000284:Administration, Oral; D000328:Adult; D000799:Angioedema / Q000139:chemically induced*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D001241:Aspirin / Q000009:adverse effects*; D052246:Cyclooxygenase 2 Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D004342:Drug Hypersensitivity / Q000175:diagnosis; D005260:Female; D006801:Humans; D008297:Male; D000077239:Meloxicam; D008875:Middle Aged; D016037:Single-Blind Method; D012882:Skin Tests; D013843:Thiazines / Q000008:administration & dosage* / Q000009:adverse effects; D013844:Thiazoles / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome; D014581:Urticaria / Q000139:chemically induced*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D052246:Cyclooxygenase 2 Inhibitors; D013843:Thiazines; D013844:Thiazoles; D001241:Aspirin; D000077239:Meloxicam